Fluid Management and Nutrition Guidelines
Base Fluid Requirements
- The European Society for Clinical Nutrition and Metabolism suggests a base fluid requirement of 1-4 ml/kg/hour of isotonic crystalloid (typically 0.9% NaCl or Ringer's lactate) 1
- The American Diabetes Association recommends potassium levels of 20-30 mEq/L in maintenance fluids once renal function is confirmed 2
Fluid Calculation
- The Holliday-Segar formula calculates fluid requirements as 100 ml/kg/day for the first 10 kg, 50 ml/kg/day for the next 10 kg, and 20 ml/kg/day for each kg above 20 kg 3
Electrolyte Management
- The American Diabetes Association recommends sodium and potassium levels of 20-40 mEq/L (2/3 KCl and 1/3 KPO₄) for children 2
- The European Society for Clinical Nutrition and Metabolism suggests chloride levels slightly lower than the sum of sodium and potassium (Na + K - Cl = 1-2 mmol/kg/day) 3
- Corrected serum sodium should be used to guide fluid selection, with normal/high corrected sodium requiring 0.45% NaCl and low corrected sodium requiring 0.9% NaCl 2
Monitoring and Adjustment
- The Society of Critical Care Medicine recommends assessing vital signs, urine output, and clinical examination several times daily to monitor for fluid overload 4
- The American Diabetes Association suggests watching for signs of fluid overload such as crepitations, increased work of breathing, or peripheral edema 2
- The European Society for Clinical Nutrition and Metabolism recommends reducing fluid rates if signs of overload appear and adjusting for ongoing losses such as fever, drains, or gastrointestinal losses 1
Nutrition Management for NPO Patients
- Ensure adequate nutrition is provided through alternative routes when patients are NPO, with a strength of evidence of high quality 5
- Nutritional compromise can occur within 2-3 weeks if adequate nutrition is not provided, with a strength of evidence of moderate quality 5
- For NPO diabetic patients, the American Diabetes Association recommends basal insulin or a basal plus bolus correction insulin regimen as the preferred treatment, with a strength of evidence of high quality 5
- Sliding scale insulin alone (without basal insulin) is discouraged for NPO diabetic patients, with a strength of evidence of moderate quality 5
- Blood glucose monitoring should be performed every 4-6 hours in patients who are not eating, with a strength of evidence of high quality 6
Swallowing Assessment and Management
- A formal swallowing assessment should be completed before resuming oral intake, with a strength of evidence of high quality 5, 7, 8
- Swallowing screening should be completed within 24 hours of hospital arrival, with a strength of evidence of moderate quality 8
- The following practices should be avoided:
- The following table summarizes the recommendations for swallowing assessment and management:
| Recommendation | Strength of Evidence |
|---|---|
| Formal swallowing assessment before resuming oral intake | High quality [5, 7, 8] |
| Swallowing screening within 24 hours of hospital arrival | Moderate quality [8] |
| Avoid administering oral medications without swallowing assessment | High quality [7, 8] |
| Avoid discontinuing tube feeds without ensuring alternative nutrition is safely established | Moderate quality [9] |
| Avoid assuming a negative CT brain scan means swallowing function is intact | Moderate quality [7, 8] |
| Avoid delaying swallowing assessment | Moderate quality [8] |
Management of Acute Gout in NPO Patients
- The American College of Rheumatology recommends intra-articular injection of corticosteroids for involvement of 1-2 joints, with a strength of evidence of moderate quality 10
- Intravenous or intramuscular methylprednisolone at an initial dose of 0.5-2.0 mg/kg is appropriate for NPO patients with acute gout, with a strength of evidence of moderate quality 10
- Subcutaneous synthetic adrenocorticotropic hormone (ACTH) at an initial dose of 25-40 IU is an alternative for NPO patients with acute gout, with a strength of evidence of low quality 10